CTRI/2010/091/000153已完成3 期
A Phase III, 12-week, Double-blind, Randomized, Parallel-group, Active-controlled, Multinational, Efficacy and Safety Study of Symbicort® Turbuhaler® 160/4.5 μg 2 Inhalations Twice Daily (Bid) Compared to Oxis® Turbuhaler® 4.5 μg 2 Inhalations Twice Daily (Bid) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •A current clinical diagnosis of COPD
- •- Documented COPD symptoms for more than 2 years
- •- A smoking history of at least 10 pack years
排除标准
- •- History and/or current clinical diagnosis of asthma
- •- History and/or current clinical diagnosis of atopic diseases such as allergic rhinitis
研究者
相似试验
未知
3 期
SUMIREJPRN-jRCT2080221041AstraZeneca
已完成
3 期
A phase III, 52 week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary diseaseCOPDchronic obstructive pulmonary disease10038716NL-OMON45240GlaxoSmithKline225
进行中（未招募）
1 期
A 12 month study to compare FF/UMEC/VI with FF/VI and UMEC/VI in patients with Chronic Obstructive Pulmonary Disease(COPD) and a history of COPD exacerbatioChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 19.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 100000004855EUCTR2013-003075-35-DEGlaxoSmithKline Research & Development Ltd10,000
进行中（未招募）
1 期
A 12 month study to compare FF/UMEC/VI with FF/VI and UMEC/VI in patients with Chronic Obstructive Pulmonary Disease(COPD) and a history of COPD exacerbatioChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 17.0 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 100000004855EUCTR2013-003075-35-NOGlaxoSmithKline Research & Development Ltd13,905
进行中（未招募）
1 期
A 12 month study to compare FF/UMEC/VI with FF/VI and UMEC/VI in patients with Chronic Obstructive Pulmonary Disease(COPD) and a history of COPD exacerbatioChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 17.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 100000004855EUCTR2013-003075-35-BEGlaxoSmithKline Research & Development Ltd10,000